Clearwater International advises Barclays Private Equity on Femcare sale

Femcare logo

Clearwater rådgiver

Pressemeddelse

Femcare Holdings Limited, the Nottingham-based internationally renowned healthcare group, has undergone a multi million pound management buy-out backed by the Midlands offices of Barclays Private Equity & Lloyds TSB Corporate Acquisition Finance.

The Femcare group provide devices for use in surgical operations in the UK and overseas. The company markets and distributes the Filshie System, a unique titanium and silicone rubber clip that is the western world’s leading female sterilisation device.

Advised by Clearwater International in the Midlands, the MBO team is being led by the current group managing director, Bernard Sweeney together with Dr Marcus Filshie – the group’s medical director and inventor of the Filshie clip, alongside Martin Nicholson – finance director and Adam McQuilkin – marketing director. Terry Watson executive chairman of Robinson Healthcare Ltd joins the board as non executive chairman.

Nikomed, which has been in existence for over 12 years, solely serves the UK market and its customer base includes; NHS Trusts, NHS Logistics and private healthcare providers. Nikomed’s competitive advantage centres on its commitment to customer service. Virtually all deliveries are despatched on the day the order is received.

“We are already a significant exporter and our future growth plans are based on increasing penetration in the global marketplace through both existing and new products.”

Bernard Sweeney, Group Managing Director, Femcare

“Femcare is a truly innovative company with excellent prospects. In particular the US market presents numerous opportunities for the group to enhance its market share and position. This is a strong, well-regarded management team and under their stewardship I expect the business to go from strength to strength.”

Jon Hustler, Partner, Clearwater International